SynAct Pharma AB (SYNACT.ST)
SynAct Pharma AB reported revenue of 0 SEK for the year ending 31 December 2025.
Every figure below is the company's own, as filed. Nothing is estimated and
nothing is smoothed — a period the filing does not support is left blank rather than
filled in.
Quarters are the company's own, counted from its financial
year ending 12-31.
Amounts in SEK.
The same series drawn ›
As last reported
The newest period the filing supports for each figure, in SEK.
| Figure | Period | Amount | Year on year |
| Revenue |
2025 · ending 31 December 2025 |
0 |
— |
| Gross Profit |
2025 · ending 31 December 2025 |
0 |
— |
| Operating Income |
2025 · ending 31 December 2025 |
-116.5M |
— |
| Net Income |
2025 · ending 31 December 2025 |
-110.8M |
— |
| Operating Cash Flow |
2025 · ending 31 December 2025 |
-97.3M |
— |
| EPS |
2025 · ending 31 December 2025 |
-2.17 |
— |
Revenue and profit by financial year
As filed, in SEK. A year the filing does not support is not listed.
| Year | Ending |
Revenue | Operating Income | Net Income | Free Cash Flow |
| 2025 | 2025-12-31 |
0 | -116.5M | -110.8M | — |
| 2024 | 2024-12-31 |
0 | -90M | -82.4M | — |
| 2023 | 2023-12-31 |
0 | -224.5M | -215.8M | — |
| 2022 | 2022-12-31 |
0 | -105.7M | -99.2M | — |
| 2021 | 2021-12-31 |
0 | -76.7M | -69.3M | — |
Every period
Revenue Annual
| Period | Ending | Revenue |
| FY25 | 2025-12-31 | 0 |
| FY24 | 2024-12-31 | 0 |
| FY23 | 2023-12-31 | 0 |
| FY22 | 2022-12-31 | 0 |
| FY21 | 2021-12-31 | 0 |
Gross Profit Annual
| Period | Ending | Gross Profit |
| FY25 | 2025-12-31 | 0 |
| FY24 | 2024-12-31 | 0 |
| FY23 | 2023-12-31 | 0 |
| FY22 | 2022-12-31 | 0 |
| FY21 | 2021-12-31 | 0 |
Operating Income Annual
| Period | Ending | Operating Income |
| FY25 | 2025-12-31 | -116.5M |
| FY24 | 2024-12-31 | -90M |
| FY23 | 2023-12-31 | -224.5M |
| FY22 | 2022-12-31 | -105.7M |
| FY21 | 2021-12-31 | -76.7M |
Net Income Annual
| Period | Ending | Net Income |
| FY25 | 2025-12-31 | -110.8M |
| FY24 | 2024-12-31 | -82.4M |
| FY23 | 2023-12-31 | -215.8M |
| FY22 | 2022-12-31 | -99.2M |
| FY21 | 2021-12-31 | -69.3M |
Operating Cash Flow Annual
| Period | Ending | Operating Cash Flow |
| FY25 | 2025-12-31 | -97.3M |
| FY24 | 2024-12-31 | -89.2M |
| FY23 | 2023-12-31 | -100.2M |
| FY22 | 2022-12-31 | -117.6M |
| FY21 | 2021-12-31 | -65M |
EPS Annual
The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.
| Period | Ending | EPS |
| FY25 | 2025-12-31 | -2.17 |
| FY24 | 2024-12-31 | -2.08 |
| FY23 | 2023-12-31 | -6.64 |
| FY22 | 2022-12-31 | -3.60 |
| FY21 | 2021-12-31 | -2.68 |